Product Development Policy | Research & Development | SENJU Pharmaceutica
to affect 537 million people worldwide, is one of three 3 major complications of diabetes mellitus (DM). It has been reported that 93 million diabetic patients worldwide (3 million in Japan) have abno...
http://www.senju.co.jp/english/rd/policy/
医療用医薬品 
医療機器 
動物用医薬品 
OTC医薬品 
サプリメント 